chr13:32914938:TTAAA> Detail (hg19) (BRCA2)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr13:32,914,938-32,914,942 |
| hg38 | chr13:32,340,801-32,340,805 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
| RefSeq | NM_000059.3:c.6446_6450delTTAAA | NP_000050.2:p.Ile2149SerfsTer25 |
| Ensemble | ENST00000380152.8:c.6446_6450delTTAAA | ENST00000380152.8:p.Ile2149SerfsTer25 |
| ENST00000530893.7:c.6077_6081delTTAAA | ENST00000530893.7:p.Ile2026SerfsTer25 |
Summary
MGeND
| Clinical significance |
|
| Variant entry | 5 |
| GWAS entry | |
| Disease area statistics | Show details |
Disease area statistics
MGeND
| Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
|---|---|---|---|---|---|---|---|---|---|
|
|
2018/01/13 | breast, unspecified |
|
MGS000028
(TMGS000049) |
Yukihide Momozawa | RIKEN |
30287823
|
||
|
|
2021/03/19 | breast |
|
MGS000048
(TMGS000112) |
Yukihide Momozawa Koichi Matsuda |
RIKEN The University of Tokyo |
|||
|
|
2021/03/19 | prostate |
|
MGS000049
(TMGS000113) |
Yukihide Momozawa Koichi Matsuda |
RIKEN The University of Tokyo |
|||
|
|
2021/03/19 | pancreatic |
|
MGS000051
(TMGS000115) |
Yukihide Momozawa Koichi Matsuda |
RIKEN The University of Tokyo |
|||
|
|
2020/04/20 | bronchus or lung, unspecified |
|
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan |
ClinVar
| Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
|---|---|---|---|---|---|
|
|
2023-11-30 | criteria provided, multiple submitters, no conflicts | hereditary breast ovarian cancer syndrome |
|
Detail |
|
|
2016-09-08 | reviewed by expert panel | Breast-ovarian cancer, familial, susceptibility to, 2 |
|
Detail |
|
|
2023-07-11 | criteria provided, multiple submitters, no conflicts | Hereditary cancer-predisposing syndrome |
|
Detail |
|
|
2020-10-01 | criteria provided, multiple submitters, no conflicts | not provided |
|
Detail |
|
|
2022-03-13 | criteria provided, single submitter | Malignant tumor of prostate,medulloblastoma,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Fanconi anemia complementation group D1,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 |
|
Detail |
|
|
2022-03-13 | criteria provided, single submitter | Malignant tumor of prostate,medulloblastoma,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Fanconi anemia complementation group D1,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 |
|
Detail |
|
|
2022-03-13 | criteria provided, single submitter | Malignant tumor of prostate,medulloblastoma,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Fanconi anemia complementation group D1,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 |
|
Detail |
|
|
2022-03-13 | criteria provided, single submitter | Malignant tumor of prostate,medulloblastoma,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Fanconi anemia complementation group D1,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 |
|
Detail |
|
|
2022-03-13 | criteria provided, single submitter | Malignant tumor of prostate,medulloblastoma,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Fanconi anemia complementation group D1,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 |
|
Detail |
|
|
2022-03-13 | criteria provided, single submitter | Malignant tumor of prostate,medulloblastoma,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Fanconi anemia complementation group D1,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 |
|
Detail |
|
|
2022-03-13 | criteria provided, single submitter | Malignant tumor of prostate,medulloblastoma,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Fanconi anemia complementation group D1,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 |
|
Detail |
|
|
2022-03-13 | criteria provided, single submitter | Malignant tumor of prostate,medulloblastoma,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,Fanconi anemia complementation group D1,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 |
|
Detail |
|
|
2022-01-21 | criteria provided, single submitter | Familial cancer of breast |
|
Detail |
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.240 | Breast-ovarian cancer, familial, susceptibility to, 2 | NA | CLINVAR | Detail | |
| 0.391 | Hereditary Breast and Ovarian Cancer Syndrome | NA | CLINVAR | Detail | |
| 0.128 | Neoplastic Syndromes, Hereditary | NA | CLINVAR | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND Hereditary breast ovarian cancer syndrome | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND Breast-ovarian cancer, familial, susceptibility ... | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND Hereditary cancer-predisposing syndrome | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND not provided | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND multiple conditions | ClinVar | Detail |
| NM_000059.4(BRCA2):c.6446_6450del (p.Ile2149fs) AND Familial cancer of breast | ClinVar | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs80359593 dbSNP
- Genome
- hg19
- Position
- chr13:32,914,938-32,914,942
- Variant Type
- snv
- Reference Allele
- TTAAA
- Alternative Allele
- -
Genome browser
